Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

A Research Study to See How Well Semaglutide Helps People Who Have a Body Weight Above the Healthy Weight Range

← catalyst calendar

NCT06041217 · results posted

Sponsored by Novo Nordisk A/S (industry) · NVO — their whole pipeline →.

Phase
Phase 3
Status
Completed
Study type
Interventional
Design
Randomized · Quadruple · Treatment
Enrollment
242actual
Sites
21
Countries
China, Taiwan

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
Start2023-09-15actualWhen the study began enrolling
Primary completion2025-04-02actualThe date the last participant is measured for the primary outcome — the readout window
Study completion2025-05-07actualThe whole study's end, after follow-up
First posted2023-09-18actualWhen this record first appeared on the registry
Results posted2026-05-18actualWhen the sponsor posted results to the registry
Record updated2026-05-18actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Conditions

  • Overweight
  • Obesity

Interventions

  • Drug: Semaglutide
  • Drug: Placebo

Primary outcomes

what the primary-completion date above is the date OF
Change in Body Weight (%)
measured Baseline (week 0), end of treatment (week 44)
Number of Participants Who Achieved Body Weight Reduction Greater Than or Equal to (≥) 5% (Yes/No)
measured At end of treatment (week 44)

Posted documents

hosted by the registry — we link, never re-serve
Study Protocolposted 2024-09-05 · 16.0 MB · Prot_000.pdf
Statistical Analysis Planposted 2025-03-27 · 2.7 MB · SAP_001.pdf

Publications

Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.

Permalink · NVO's whole pipeline · Catalyst calendar · Every registered study · What changed